跳至主要内容
临床试验/NCT04014595
NCT04014595进行中(未招募)不适用

The Evaluation of a Strategy to PREPARE Severely CALCified Coronary Lesions With a Combination Of Rotational Atherectomy and Modified BallOons Trial (PREPARE-CALC- COMBO)

Segeberger Kliniken GmbH1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
1
主要终点
Primary endpoint: Numerical in-stent acute lumen gain in mm

研究概览

简要总结

A prospective single-arm trial of rotational atherectomy in combination with cutting balloon in severely calcified coronary lesions.

详细描述

A prospective single-arm trial to evaluate the acute and long term efficacy of a combined strategy of lesion preparation with rotational atherectomy followed by cutting balloon and by hybrid sirolimus-eluting stent implantation in an angiographically well-defined group of patients with severely calcified coronary lesions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical inclusion criteria
  • Age above 18 years and consentable
  • Angiographically proven coronary artery disease
  • Anginal symptoms and/or reproducible ischemia in the target area by ECG, functional stress testing or fractional flow reserve
  • Written informed consent
  • Angiographic inclusion criteria
  • De-novo lesion in a native coronary artery
  • Target reference vessel diameter between 2.25 and 4.0 mm by visual estimation
  • Luminal diameter reduction of 50-100% by visual estimation
  • Severe calcification of the target lesion (for definition see appendix)

排除标准

  • Clinical exclusion criteria
  • Myocardial infarction (within 1 week)
  • Decompensated heart failure
  • Limited long term prognosis due to other conditions
  • Angiographic exclusion criteria
  • Target lesion is in a coronary artery bypass graft
  • Target lesion is an in-stent restenosis
  • Target vessel thrombus

结局指标

主要结局

Primary endpoint: Numerical in-stent acute lumen gain in mm

时间窗: At the end of the index procedure

The main angiographic endpoint will be in-stent acute lumen gain defined as minimal lumen diameter (MLD) in stent at the end of the index procedure minus baseline MLD.

Co-primary OCT endpoint: Ratio of stent expansion index (SEI)

时间窗: At the end of the index procedure

The main OCT endpoint will be stent expansion index (SEI), defined as minimum stent area divided by mean reference area in optical coherence tomography (OCT) quantitative analysis at the end of the index procedure

次要结局

  • Numerical in-stent late lumen loss at 9 month follow-up angiography in mm(9 months follow-up)
  • Rate of angiographic success in percent(Peri-procedural)
  • Rate of in-segment binary restenosis at 9 months in percent(9 months follow-up)
  • Rate of strategy success in percent(Peri-procedural)
  • Rate of target vessel failure in percent(9 months, 1 and 2 years follow-up)
  • Rate of peri-procedural myocardial infarction in percent(Peri-procedural)
  • Numerical procedural duration in min(Peri-procedural)
  • Numerical contrast dye amount in ml(Peri-procedural)
  • Rate of stent thrombosis in percent(9 months, 1 and 2 years follow-up and final 5 years follow-up)
  • Rate of vessel perforation in percent(Peri-procedural)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

PREPARE-CALC-COMBO: Severely Calcified Coronary... | 临床试验